6.
Dunn R, Ben Husien M
. Spinal tuberculosis: review of current management. Bone Joint J. 2018; 100-B(4):425-431.
DOI: 10.1302/0301-620X.100B4.BJJ-2017-1040.R1.
View
7.
Rama Krishna M, Gottam U, Mahendra N
. Disseminated tuberculosis with severe immune thrombocytopenia. Respir Med Case Rep. 2019; 27:100812.
PMC: 6430074.
DOI: 10.1016/j.rmcr.2019.02.013.
View
8.
Dean A, Zyck S, Toshkezi G, Galgano M, Marawar S
. Challenges in the Diagnosis and Management of Spinal Tuberculosis: Case Series. Cureus. 2019; 11(1):e3855.
PMC: 6411342.
DOI: 10.7759/cureus.3855.
View
9.
Rivas-Garcia A, Sarria-Estrada S, Torrents-Odin C, Casas-Gomila L, Franquet E
. Imaging findings of Pott's disease. Eur Spine J. 2012; 22 Suppl 4:567-78.
PMC: 3691403.
DOI: 10.1007/s00586-012-2333-9.
View
10.
Nayak S, Acharjya B
. VDRL test and its interpretation. Indian J Dermatol. 2012; 57(1):3-8.
PMC: 3312652.
DOI: 10.4103/0019-5154.92666.
View
11.
Monin L, Khader S
. Chemokines in tuberculosis: the good, the bad and the ugly. Semin Immunol. 2014; 26(6):552-8.
PMC: 4314384.
DOI: 10.1016/j.smim.2014.09.004.
View
12.
Kanna R, Babu N, Kannan M, Shetty A, Rajasekaran S
. Diagnostic accuracy of whole spine magnetic resonance imaging in spinal tuberculosis validated through tissue studies. Eur Spine J. 2019; 28(12):3003-3010.
DOI: 10.1007/s00586-019-06031-z.
View
13.
Djordjevic D, Rondovic G, Surbatovic M, Stanojevic I, Udovicic I, Andjelic T
. Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of.... Mediators Inflamm. 2018; 2018:3758068.
PMC: 6079471.
DOI: 10.1155/2018/3758068.
View
14.
Cooper A
. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol. 2009; 27:393-422.
PMC: 4298253.
DOI: 10.1146/annurev.immunol.021908.132703.
View
15.
Jones B, Oo M, Taikwel E, Qian D, Kumar A, Maslow E
. CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clin Infect Dis. 1997; 24(5):988-91.
DOI: 10.1093/clinids/24.5.988.
View
16.
Chowdhury R, Vallania F, Yang Q, Lopez Angel C, Darboe F, Penn-Nicholson A
. A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes. Nature. 2018; 560(7720):644-648.
PMC: 6414221.
DOI: 10.1038/s41586-018-0439-x.
View
17.
Batirel A, Erdem H, Sengoz G, Pehlivanoglu F, Ramosaco E, Gulsun S
. The course of spinal tuberculosis (Pott disease): results of the multinational, multicentre Backbone-2 study. Clin Microbiol Infect. 2015; 21(11):1008.e9-1008.e18.
DOI: 10.1016/j.cmi.2015.07.013.
View
18.
Shi T, Zhang Z, Dai F, Zhou Q, He Q, Luo F
. Retrospective Study of 967 Patients With Spinal Tuberculosis. Orthopedics. 2016; 39(5):e838-43.
DOI: 10.3928/01477447-20160509-03.
View
19.
Qian J, Rijiepu A, Zhu B, Tian D, Chen L, Jing J
. Outcomes of radical debridement versus no debridement for the treatment of thoracic and lumbar spinal tuberculosis. Int Orthop. 2016; 40(10):2081-2088.
DOI: 10.1007/s00264-016-3234-z.
View
20.
Kilborn T, Janse van Rensburg P, Candy S
. Pediatric and adult spinal tuberculosis: imaging and pathophysiology. Neuroimaging Clin N Am. 2015; 25(2):209-31.
DOI: 10.1016/j.nic.2015.01.002.
View